2933.99.42 | 00 | Anti-infective agents: | | | | |
2933.99.42 | 00 | Acriflavine; Acriflavine hydrochloride; Carbadox; and Pyrazinamide | kg | Free | | 15.4¢/kg + 46% |
2933.99.51 | 00 | Hydralazine hydrochloride | kg | Free | | 15.4¢/kg + 47.5% |
2933.99.55 | 20 | Tolmetin sodium dihydrate | kg | | | |
2933.99.55 | 30 | Tolmetin sodium (anhydrous) | kg | | | |
2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
2933.99.55 | | Analgesics, antipyretics and nonhormonal anti-inflammatory agents | | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4¢/kg + 47.5% |
2933.99.55 | 10 | Tolmetin | kg | | | |
2933.99.58 | 00 | Droperidol; and Imipramine hydrochloride | kg | Free | | 15.4¢/kg + 45.5% |
2933.99.79 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
2933.99.85 | 00 | 3-Amino-1,2,4-triazole | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
2933.99.87 | 00 | Hexamethylenetetramine | kg | 6.3% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 58% |
2933.99.89 | 00 | Hexamethyleneimine | kg | Free | | 30.5% |
2934 | | Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: | | | | |
2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
2934.10.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
2934.10.70 | 00 | 4,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloride | kg | Free | | 30.5% |
2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
2934.20.25 | 00 | 2-Amino-5,6-dichlorobenzothiazole; 2-(4-Aminophenyl)-6-methylbenzothiazole-7- sulfonic acid; 2-Amino-6-nitrobenzothiazole; and N,N-Dicyclohexyl-2-benzothiazolesulfenamide | kg | Free | | 15.4¢/kg + 52% |
2934.20.30 | 00 | 2-Amino-6-methoxybenzothiazole; 2-Amino-6-methylbenzothiazole; 6-Ethoxy-2-benzothiazolethiol; 3-Methylbenzothiazole-2-hydrazone; and Primuline base | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
2934.20.40 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
2934.30.12 | 00 | 2-(Trifluoromethyl)phenothiazine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 45% |
2934.30.18 | 00 | Ethyl (1H-phenothiazin-2,4,1)carbamate | kg | Free | | 15.4¢/kg + 52% |
2934.30.43 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |